Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function—ONWARDS 1–5

Diabetologie und Stoffwechsel 2025; 20(S 01): S43
DOI: 10.1055/s-0045-1807439

Abstracts | DDG 2025

Poster

Posterwalk 5: Diabeteskomplikationen I Niere I Fuß

Authors

M Kellerer

¹Marienhospital Stuttgart, Innere Medizin 1, Stuttgart, Germany
P Rossing

²Steno Diabetes Center Copenhagen, Complication Research, Herlev, Denmark
M Benamar

³Novo Nordisk A/S, Global Medical Affairs, Søborg, Denmark
AY Y Cheng

⁴University of Toronto, Department of Medicine, Toronto, Canada
C Laugesen

⁵Steno Diabetes Center Copenhagen, Clinical Research, Herlev, Denmark
P H Nielsen

⁶Novo Nordisk A/S, R&D, Søborg, Denmark
H S Bajaj

⁷LMC Diabetes and Endocrinology Brampton and, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada